BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19791515)

  • 1. DNA damage and repair of head and neck cancer cells after radio- and chemotherapy.
    Rusin P; Walczak A; Zwierzchlejska A; Olszewski J; Morawiec-Bajda A; Kaczmarczyk D; Kusmierczyk K; Garncarek P; Pytel D; Sliwinński T; Majsterek I
    Z Naturforsch C J Biosci; 2009; 64(7-8):601-10. PubMed ID: 19791515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer.
    Sliwinski T; Markiewicz L; Rusin P; Kabzinski J; Dziki L; Milonski J; Olszewski J; Blaszczyk J; Szemraj J; Majsterek I
    Mutat Res; 2011 Nov; 716(1-2):51-8. PubMed ID: 21875606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of DNA damage and repair in head and neck cancer after radiation treatment.
    Rusin P; Olszewski J; Morawiec-Bajda A; Przybylowska K; Kaczmarczyk D; Golinska A; Majsterek I
    Cell Biol Int; 2009 Mar; 33(3):357-63. PubMed ID: 19385033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of impaired DNA repair in genotoxic susceptibility of patients with head and neck cancer.
    Rusin P; Olszewski J; Morawiec-Bajda A; Przybylowska K; Kaczmarczyk D; Golinska A; Majsterek I
    Cell Biol Toxicol; 2009 Oct; 25(5):489-97. PubMed ID: 18787964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA double strand breaks repair and apoptosis induction in peripheral blood lymphocytes of head and neck cancer patients.
    Rusin P; Markiewicz L; Olszewski J; Morawiec-Sztandera A; Kowalski M; Przybylowska K; Kaczmarczyk D; Kusmierczyk K; Majsterek I
    Exp Oncol; 2009 Sep; 31(3):168-73. PubMed ID: 19783963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of chemoresistance in head and neck squamous cell carcinoma].
    Zhao YX; Sun ZF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):888-891. PubMed ID: 29775010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
    J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DNA double strand breaks repair efficiency in head and neck cancer.
    Walczak A; Rusin P; Dziki L; Zielinska-Blizniewska H; Olszewski J; Majsterek I
    DNA Cell Biol; 2012 Mar; 31(3):298-305. PubMed ID: 21875370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hypoxia by measurement of DNA damage and repair in human lymphocytes (comet assay): a predictive variable for tumor response during chemotherapy in patients with head and neck squamous cell carcinoma.
    Romanet T; Ré JL; De Méo M; Serre-Debeauvlais F; Lavieille JP; Reyt E; Riva C
    In Vivo; 1999; 13(4):343-8. PubMed ID: 10586376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
    Nowsheen S; Bonner JA; Yang ES
    Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests.
    Palyvoda O; Polańska J; Wygoda A; Rzeszowska-Wolny J
    Acta Biochim Pol; 2003; 50(1):181-90. PubMed ID: 12673358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
    Rusz O; Pál M; Szilágyi É; Rovó L; Varga Z; Tomisa B; Fábián G; Kovács L; Nagy O; Mózes P; Reisz Z; Tiszlavicz L; Deák P; Kahán Z
    Pathol Oncol Res; 2017 Apr; 23(2):253-264. PubMed ID: 27411922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay.
    Saha DT; Davidson BJ; Wang A; Pollock AJ; Orden RA; Goldman R
    Mutat Res; 2008 Jan; 650(1):55-62. PubMed ID: 18032094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay.
    Terris DJ; Ho EY; Ibrahim HZ; Dorie MJ; Kovacs MS; Le QT; Koong AC; Pinto HA; Brown JM
    Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):698-702. PubMed ID: 12049567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients.
    Baumeister P; Schwenk-Zieger S; Reiter M; Welz C; Harréus U
    Mutat Res; 2009; 677(1-2):42-5. PubMed ID: 19539778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
    Hoffmann TK; Sonkoly E; Hauser U; van Lierop A; Whiteside TL; Klussmann JP; Hafner D; Schuler P; Friebe-Hoffmann U; Scheckenbach K; Erjala K; Grénman R; Schipper J; Bier H; Balz V
    Oral Oncol; 2008 Dec; 44(12):1100-9. PubMed ID: 18487078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells.
    Storch K; Cordes N
    Int J Oncol; 2016 Jan; 48(1):191-8. PubMed ID: 26573875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.